These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19304140)

  • 1. Delayed gadolinium enhancement and elevated plasma brain natriuretic peptide are useful in differentiating hypertrophic cardiomyopathy from athlete's heart.
    Cheng TO
    J Cardiol; 2009 Apr; 53(2):314-5; author reply 315. PubMed ID: 19304140
    [No Abstract]   [Full Text] [Related]  

  • 2. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy.
    Oka K; Tsujino T; Nakao S; Lee-Kawabata M; Ezumi A; Masai M; Ohyanagi M; Masuyama T
    J Cardiol; 2008 Oct; 52(2):146-53. PubMed ID: 18922389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Athlete's heart or hypertrophic cardiomyopathy: usefulness of N-terminal pro-brain natriuretic peptide.
    Godon P; Griffet V; Vinsonneau U; Caignault JR; Prevosto JM; Quiniou G; Guerard S
    Int J Cardiol; 2009 Sep; 137(1):72-4. PubMed ID: 18676044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide and the athlete's heart: a pilot study.
    Pagourelias ED; Giannoglou G; Kouidi E; Efthimiadis GK; Zorou P; Tziomalos K; Karagiannis A; Athyros VG; Geleris P; Mikhailidis DP
    Int J Clin Pract; 2010 Mar; 64(4):511-7. PubMed ID: 20456196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of extended-length electrocardiogram in differentiating between athlete's heart and hypertrophic cardiomyopathy.
    Caselli L; Galanti G; Padeletti L; Nieri M; Cecchi F; Cipollini F; Baldi M; Perrotta L; Vignini S; Michelucci A
    J Electrocardiol; 2009; 42(6):636-41. PubMed ID: 19577245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging hypertrophic heart diseases with cardiovascular MR.
    Proctor RD; Shambrook JS; McParland P; Peebles CR; Brown IW; Harden SP
    Clin Radiol; 2011 Feb; 66(2):176-86. PubMed ID: 21216334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.
    Maron BJ
    Br J Sports Med; 2009 Sep; 43(9):649-56. PubMed ID: 19734498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating the athlete's heart from hypertrophic cardiomyopathy.
    Wasfy MM; Weiner RB
    Curr Opin Cardiol; 2015 Sep; 30(5):500-5. PubMed ID: 26196658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy: cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy.
    Mabru M; Dacher JN; Bauer F
    Arch Cardiovasc Dis; 2010 Jan; 103(1):55-6. PubMed ID: 20142122
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 13. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy.
    Puntmann VO; Jahnke C; Gebker R; Schnackenburg B; Fox KF; Fleck E; Paetsch I
    Am J Cardiol; 2010 Oct; 106(7):1016-22. PubMed ID: 20854967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparity between unusual left ventricular morphology and clinical presentation and course in hypertrophic cardiomyopathy.
    Maron BJ; Lindberg J; Haas TS; Kitner C; Lesser JR
    Am J Cardiol; 2010 Jun; 105(11):1643-4. PubMed ID: 20494677
    [No Abstract]   [Full Text] [Related]  

  • 17. Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy.
    Romero-Puche A; Marín F; González-Carrillo J; García-Honrubia A; Climent V; Feliu E; Ruiz-Espejo F; Payá E; Gimeno-Blanes JR; de la Morena G; Valdés-Chavarri M
    Rev Esp Cardiol; 2008 Aug; 61(8):853-60. PubMed ID: 18684368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity.
    Aquaro GD; Masci P; Formisano F; Barison A; Strata E; Pingitore A; Positano V; Spirito P; Lombardi M
    Am J Cardiol; 2010 Feb; 105(3):392-7. PubMed ID: 20102955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance.
    Maron BJ
    Heart; 2005 Nov; 91(11):1380-2. PubMed ID: 16230430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy in athletes.
    Rawlins J; Bhan A; Sharma S
    Eur J Echocardiogr; 2009 May; 10(3):350-6. PubMed ID: 19246500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.